Related Experiment Video
Updated: Apr 27, 2026

08:31
A Closed-Type Wireless Nanopore Electrode for Analyzing Single Nanoparticles
Published on: March 20, 2019
6.8K
Ultrasensitive electrochemical biomolecular detection using nanostructured microelectrodes.
Andrew T Sage1, Justin D Besant, Brian Lam
1Department of Pharmaceutical Sciences, University of Toronto , Toronto, Ontario, Canada M5S 3M2.
Accounts of Chemical Research
|June 26, 2014
Summary
This study presents a novel electrochemical sensor platform for sensitive and specific biomolecule detection. The integrated system enables rapid, low-cost, lab-free diagnostics for various clinical applications.
Area of Science:
- Electrochemistry
- Nanotechnology
- Biomolecular Detection
- Point-of-Care Diagnostics
Background:
- Current diagnostic methods (PCR, microarrays, gene sequencing) are often slow, expensive, and not suitable for lab-free use.
- Electrochemical sensors offer a promising alternative for sensitive, specific, and low-cost biomolecule detection.
- There is a need for integrated platforms for routine biomarker monitoring in patient treatment.
Purpose of the Study:
- To summarize advances in electrochemical biomolecular detection using an integrated platform.
- To highlight the development of multiplexed electrochemical sensors fabricated from electrodeposited noble metals.
- To demonstrate a novel electrocatalytic assay for ultrasensitive analyte detection and its application in clinical diagnostics.
Main Methods:
- Development of nanostructured microelectrodes (NMEs) from gold nanoelectrode ensembles.
- Utilizing a novel electrocatalytic assay involving Ru(3+) adsorption and Fe(3+) amplification.
- Employing a simple potentiostat for electrochemical measurements, enabling integration into portable devices.
- Functionalizing NMEs with capture probes for specific detection of nucleic acids, small molecules, and proteins.
Main Results:
- Achieved attomolar detection levels for nucleic acids with assay times as short as 2 minutes.
- Demonstrated successful detection of a wide range of analytes at clinically relevant concentrations.
- Enabled measurement of uncharged analytes, overcoming a limitation of charge-dependent reporter systems.
- Applied the platform to detect pathogenic species and cancer biomarkers in complex clinical samples.
Conclusions:
- The developed electrochemical platform offers high specificity and sensitivity for detecting low-concentration analytes in complex matrices.
- The integrated system, utilizing nanostructured microelectrodes and a redox-cycling readout, provides large molecular-to-electrical amplification.
- This technology has the potential to overcome limitations of traditional methods, enabling practical, cost-effective, lab-free diagnostics for various clinical challenges.

